Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT03599518
Status:
TERMINATED
Last Update Posted:
2023-02-08
First Post:
2018-07-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Sponsor:
Daiichi Sankyo Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-16
First Submit QC Date:
None
Study First Post Date:
2018-07-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-14
Results First Submit QC Date:
None
Results First Post Date:
2023-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-13
Last Update Post Date:
2023-02-08
Last Update Post Date Type:
ACTUAL